Abstract OBJECTIVE: To investigate the treatment outcome and risk factors for intractable seizures in children with tuberous sclerosis complex（TSC）complicated by epilepsy. METHODS: The medical data of 66 cases of TSC were retrospectively studied. RESULTS: Of the 66 children with TSC, 47 cases were available for follow-up. The follow-up period ranged from 7 months to 9.3 years (average 4.5±2.6 years). The patients′ present average age was (7.7±4.1) years (median 8 years). Among the 47 cases, 19 (40%) had infantile spasms, 24 (51%) had tonic seizures, 15 (32%) had partial seizures, and 3 (6%) had tonic-clonic seizures, and additionally, multifocal seizures, atonic seizures, atypical absence seizures and hypomotor seizures each appeared in 1 case (2%) respectively. The average number of antiepileptic drugs used was 1.9±0.86 (median 1). Among the 47 patients, 12 (26%) still had epileptic seizures and 33 (70%）were seizure-free, and 4% were dead. Three cases underwent surgery and continued to receive medication after surgery. The three patients were seizurefree in a 1.5 years follow-up. Among the 30 children over 7 years old, 17 cases (57%) were enrolled in ordinary schools, 3 cases (10%) in special schools and the other 10 cases were off-school for disabilities of intelligence and speech. The non conditional logistic regression showed that the age of onset (RR=1.8, 95% CI 1.0- 3.2, P=0.050), administration of multiple antiepileptic drugs (RR=4.8, 95% CI 1.2-18.6, P=0.024), tonic seizures (RR=0.003, 95% CI 0.0- 0.2, P=0.04) and sex (RR=0.016, 95% CI 0.0-0.5, P=0.017) were risk factors for intractable seizures. CONCLUSIONS: The majority (70%) of children with TSC complicated by epilepsy can be seizure-free with suitable treatment. The risk factors of poor outcome in seizure control may involve in the early onset age, tonic seizures and the administration for multiple anti-epileptic drugs.［Chin J Contemp Pediatr, 2009, 11 (12):996-998］
WEN Jia-Lun,LIAO Jian-Xiang,CHEN Li et al. Follow-up of tuberous sclerosis complex complicated by epilepsy in children[J]. 中国当代儿科杂志, 2009, 11(12): 996-998.
WEN Jia-Lun,LIAO Jian-Xiang,CHEN Li et al. Follow-up of tuberous sclerosis complex complicated by epilepsy in children[J]. CJCP, 2009, 11(12): 996-998.
［6］Schwartz RA, Fernández G, Kotulska K, Jó'zwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management［J］.J Am Acad Dermatol, 2007, 57(2):189-202.
［7］Curatolo P, Bombardieri R, Cerminara C.Current management for epilepsy in tuberous sclerosis complex［J］.Curr Opin Neurol, 2006, 19(2):119-123.
［8］Kwan P, Brodie MJ. Early identification of refractory epilepsy［J］. N Engl J Med, 2000, 342(5):314-319.
［9］Jansen FE, van Huffelen AC, Algra A, van Nieuwenhuizen O. Epilepsy surgery in tuberous sclerosis: a systematic review［J］.Epilepsia, 2007, 48(8):1477-1484.
［10］Madhavan D, Schaffer S, Yankovsky A, Arzimanoglou A, Renaldo F, Zaroff CM, et al. Surgical outcome in tuberous sclerosis complex: a multicenter survey［J］.Epilepsia, 2007, 48(8):1625-1628.
［11］Jansen FE, Van Huffelen AC, Van Rijen PC, Leijten FS, Jennekens-Schinkel A, Gosselaar P, et al. Epilepsy surgery in tuberous sclerosis: the Dutch experience［J］.Seizure, 2007, 16(5):445-453.
［12］Lachhwani DK, Pestana E, Gupta A, Kotagal P, Bingaman W, Wyllie E. Identification of candidates for epilepsy surgery in patients with tuberous sclerosis［J］.Neurology, 2005, 64(9):1651-1654.
［14］Chandra PS, Salamon N, Nguyen ST, Chang JW, Huynh MN, Cepeda C, et al. Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia［J］.Neurology, 2007, 68(6):438-445.
［15］Zaroff CM, Barr WB, Carlson C, LaJoie J, Madhavan D, Miles DK, et al.Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex［J］. Seizure, 2006, 15(7):558-562.
